ARTICLE | Clinical News
MyoCell: Phase III started
July 15, 2013 7:00 AM UTC
Bioheart began the double-blind, placebo-controlled, North and South American Phase III MIRROR trial to evaluate MyoCell in up to 126 patients. Bioheart said FDA also placed a hold on its request for ...